Maravai LifeSciences Holdings, Inc. Deferred Tax Assets, Capital Loss Carryforwards
Maravai LifeSciences Holdings, Inc. (MRVI) had Deferred Tax Assets, Capital Loss Carryforwards of $3.34 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Capital Loss Carryforwards $3.34M.
- 2024-12-31: Deferred Tax Assets, Capital Loss Carryforwards $3.25M.
- 2023-12-31: Deferred Tax Assets, Capital Loss Carryforwards $3.26M.
- 2022-12-31: Deferred Tax Assets, Capital Loss Carryforwards $3.27M.
| Period end | Deferred Tax Assets, Capital Loss Carryforwards |
|---|---|
| 2025-12-31 | $3.34M 10-K · filed 2026-02-26 |
| 2024-12-31 | $3.25M 10-K · filed 2026-02-26 |
| 2023-12-31 | $3.26M 10-K · filed 2025-03-18 |
| 2022-12-31 | $3.27M 10-K · filed 2024-02-29 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-28 |